Although a direct association between galectin-3 concentration and BP measurements has not been clearly confirmed in clinical studies, numerous experimental data imply that gal-3 may play a role in the pathogenesis of AH through its impact on vascular stiffness, vascular remodeling, and endothelial dysfunction. The gene discussed is LGALS3; the disease is endothelial dysfunction.